[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Breaking news suggests significant US-India trade deals are on the horizon, potentially boosting US exports and jobs, while biotech acquisition rumors are swirling around companies with promising metabolic disease treatments.
$1020b is a cryptocurrency and its associated ecosystem.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXXX +313%
X Month: XXXXXXX +1,222%
X Months: XXXXXXXXX +22%
X Year: XXXXXXXXX +27%
1-Year High: XXXXXXX on 2025-04-22
1-Year Low: X on 2025-06-25
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: XX -XX%
X Month: XXX +43%
X Months: XXX +509%
X Year: XXX +690%
1-Year High: XX on 2025-11-17
1-Year Low: X on 2024-12-16
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $1020b in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
X Week: XX -XX%
X Month: XX +79%
X Months: XXX +278%
X Year: XXX +259%
1-Year High: XX on 2025-11-17
1-Year Low: X on 2024-12-16
The most influential creators that mention $1020b in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @grok | X | XXXXXXXXX | X | X |
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"No confirmation of a new $650M aid approval by Trump or Congress in December 2025 from official sources like White House or Earlier NDAA (Sep 2025) included $650M for US-Israel defense. Total US aid/arms to Israel since Jan 2025 appears to be $10-20B across multiple packages on top of annual $3.8B. Israel is seeking a longer-term increase"
X Link @grok 2025-12-11T16:30Z 6.8M followers, XX engagements
"cheaper more effective faster acting and up to -XX% weight loss. That's $10BN peak sales. Premium in MASH has been about 1-2x. So a $10-20B buyout valuation. Now discount that for a XX% PoS as they close out p2b now"
X Link @John_Porter10 2025-12-09T14:01Z 5016 followers, XX engagements
"This list is 1-2 years old $ITCI $BPC $INSM $RNA and $VRNA are already gone @BigChodu @DueDoctor @seedy19tron @haodongvli @BowTiedBiotech"
X Link @Varro_Analytics 2025-12-05T00:18Z 7238 followers, 1554 engagements
"If Evercore is really signaling $1020B takeouts coming in obesity/metabolic theres only one name that actually fits that profile: $ALT Altimmune. Why Because Pemvidutide isnt another GLP-1 copy. Its the only late-stage asset that hits every strategic gap Big Pharma cares about right now: True MASH efficacy + fibrosis improvement Best-in-class lean mass preservation Cleaner tolerability without the brutal nausea curves A GLP-1/GC balance that covers obesity metabolic disease and liver disease in one shot Pipeline in a drug; Obesity MASH AUD ALD and potentially oral Thats not incremental thats"
X Link @PGainz96934 2025-12-04T19:47Z XXX followers, 1118 engagements